Pembrolizumab therapy for microsatellite instability high (MSI-H) colorectal cancer (CRC) and non-CRC
Diaz, Luis A., Marabelle, Aurelien, Delord, Jean-Pierre, Shapira-Frommer, Ronnie, Geva, Ravit, Peled, Nir, Kim, Tae Won, Andre, Thierry, Van Cutsem, Eric, Guimbaud, Rosine, Jaeger, Dirk, Elez, Elena, Yoshino, Takayuki, Joe, Andrew K., Lam, Baohoang, Gause, Christine K., Pruitt, Scott Knowles, Kang, S. Peter, Le, Dung T
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
KEYNOTE-062: Phase 3 study of pembrolizumab alone or in combination with chemotherapy versus chemotherapy alone as first-line therapy for advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma
Tabernero, Josep, Bang, Yung-Jue, Fuchs, Charles S., Ohtsu, Atsushi, Kher, Uma, Lam, Baohoang, Koshiji, Minori, Van Cutsem, Eric
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
KEYNOTE-062: Phase III study of pembrolizumab (MK-3475) alone or in combination with chemotherapy versus chemotherapy alone as first-line therapy for advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma
Tabernero, Josep, Bang, Yung-Jue, Fuchs, Charles S., Ohtsu, Atsushi, Kher, Uma, Lam, Baohoang, Koshiji, Minori, Van Cutsem, Eric
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article
Pembrolizumab (MK-3475) plus 5-fluorouracil (5-FU) and cisplatin for first-line treatment of advanced gastric cancer: Preliminary safety data from KEYNOTE-059
Fuchs, Charles S., Ohtsu, Atsushi, Tabernero, Josep, Van Cutsem, Eric, Wang, Jiang Dian, Lam, Baohoang, Koshiji, Minori, Bang, Yung-Jue
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article
Pembrolizumab (MK-3475) for recurrent or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma: Multicohort phase II KEYNOTE-059 study
Fuchs, Charles S., Denker, Andrew E., Tabernero, Josep, Van Cutsem, Eric, Ohtsu, Atsushi, Lam, Baohoang, Koshiji, Minori, Bang, Yung-Jue
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article
KEYNOTE-177: Randomized phase III study of pembrolizumab versus investigator-choice chemotherapy for mismatch repair-deficient or microsatellite instability-high metastatic colorectal carcinoma
Diaz, Luis A., Le, Dung T., Yoshino, Takayuki, Andre, Thierry, Bendell, Johanna C., Koshiji, Minori, Zhang, Yinghua, Kang, S. Peter, Lam, Baohoang, Jäger, Dirk
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Multicohort phase II KEYNOTE-059 study of pembrolizumab (MK-3475) for recurrent or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
Fuchs, Charles S., Denker, Andrew E., Tabernero, Josep, Van Cutsem, Eric, Ohtsu, Atsushi, Lam, Baohoang, Koshiji, Minori, Bang, Yung-Jue
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
KEYNOTE-177: First-line, open-label, randomized, phase 3 study of pembrolizumab versus investigator-choice chemotherapy for mismatch repair-deficient or microsatellite instability-high metastatic colorectal carcinoma
Diaz, Luis A., Le, Dung T., Yoshino, Takayuki, Andre, Thierry, Bendell, Johanna C., Koshiji, Minori, Zhang, Yinghua, Kang, S. Peter, Lam, Baohoang, Jäger, Dirk
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Preliminary safety data from KEYNOTE-059: Pembrolizumab plus 5-fluorouracil (5-FU) and cisplatin for first-line treatment of advanced gastric cancer
Fuchs, Charles S., Ohtsu, Atsushi, Tabernero, Josep, Van Cutsem, Eric, Wang, Jiang Dian, Lam, Baohoang, Dalal, Rita, Koshiji, Minori, Bang, Yung-Jue
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
KEYNOTE-177: First-line, open-label, randomized, phase III study of pembrolizumab (MK-3475) versus investigator-choice chemotherapy for mismatch repair deficient or microsatellite instability-high metastatic colorectal carcinoma
Diaz, Luis A., Le, Dung T., Yoshino, Takayuki, Andre, Thierry, Bendell, Johanna C., Zhang, Yinghua, Lam, Baohoang, Koshiji, Minori, Jäger, Dirk
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article